Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Mucosal Immunol ; 11(2): 474-485, 2018 03.
Article in English | MEDLINE | ID: mdl-28766554

ABSTRACT

Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to complications like arthritis and irritable bowel syndrome. Although studies exist in animal and cell models, we aimed at a functional and structural characterization of intestinal dysfunction and the involved regulatory mechanisms in human colon. First, in patients' colonic biopsies, sodium malabsorption was identified as an important diarrheal mechanism resulting from hampered epithelial ion transport via impaired epithelial sodium channel (ENaC) ß- and γ-subunit. In addition, barrier dysfunction from disrupted epithelial tight junction proteins (claudin-1, -3, -4, -5, and -8), epithelial apoptosis, and appearance of lesions was detected, which cause leak-flux diarrhea and can perpetuate immune responses. Importantly, these effects in human biopsies either represent direct action of Campylobacter jejuni (ENaC impairment) or are caused by proinflammatory signaling (barrier dysfunction). This was revealed by regulator analysis from RNA-sequencing (cytometric bead array-checked) and confirmed in cell models, which identified interferon-γ, TNFα, IL-13, and IL-1ß. Finally, bioinformatics' predictions yielded additional information on protective influences like vitamin D, which was confirmed in cell models. Thus, these are candidates for intervention strategies against C. jejuni infection and post-infectious sequelae, which result from the permissive barrier defect along the leaky gut.


Subject(s)
Campylobacter Infections/immunology , Campylobacter jejuni/physiology , Colon/immunology , Enteritis/immunology , Intestinal Mucosa/metabolism , Malabsorption Syndromes/immunology , Sodium/metabolism , Adult , Apoptosis , Cells, Cultured , Colon/microbiology , Computational Biology , Cytokines/genetics , Cytokines/metabolism , Enteritis/microbiology , Epithelial Sodium Channels/metabolism , Female , Humans , Inflammation Mediators/metabolism , Intestinal Mucosa/pathology , Ion Transport , Malabsorption Syndromes/microbiology , Male , Middle Aged , Signal Transduction , Tight Junction Proteins/metabolism , Vitamin D/metabolism
3.
Mucosal Immunol ; 7(2): 369-78, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23900194

ABSTRACT

The probiotic Escherichia coli Nissle 1917 (EcN) is widely used to maintain remission in ulcerative colitis. This is thought to be mediated by various immunomodulatory and barrier-stabilizing effects in the intestine. In this study, the mechanisms of barrier modulation by EcN were studied in the human epithelial HT-29/B6 cell culture model.EcN supernatant increased transepithelial resistance (TER) and reduced permeability to mannitol because of sealing of the paracellular passage pathway as revealed by two-path impedance spectroscopy. This increase in TER was attributed to the TcpC protein of EcN. TcpC induced protein kinase C-ζ (PKCζ) and extracellular-signal-regulated kinase 1/2 (ERK1/2) phosphorylation, which in turn resulted in upregulation of the barrier-forming tight junction protein claudin-14. By specific silencing of protein expression by small interfering RNA (siRNA), the sealing function of claudin-14 was confirmed. In conclusion, the TcpC protein of EcN affects innate immunity by improving intestinal barrier function through upregulation of claudin-14 via PKCζ and ERK1/2 signaling.


Subject(s)
Escherichia coli Proteins/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Mucous Membrane/immunology , Mucous Membrane/metabolism , Protein Kinase C/metabolism , Virulence Factors/metabolism , Animals , Animals, Newborn , Cell Line , Claudins/metabolism , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Escherichia coli Proteins/pharmacology , Gene Knockout Techniques , HT29 Cells , Humans , Mucous Membrane/drug effects , Permeability , Phosphorylation/drug effects , Signal Transduction/drug effects , Swine , Virulence Factors/genetics , Virulence Factors/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...